| 1 |
34817888 | Apolipoprotein C-III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria. | 2022 Mar |
2 |
| 2 |
34907968 | Dietary fat and carbohydrate affect the metabolism of protein-based high-density lipoprotein subspecies. | 2022 Feb 1 |
3 |
| 3 |
35171673 | Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia. | 2022 Feb 18 |
1 |
| 4 |
35187136 | Targeting ApoC3 Paradoxically Aggravates Atherosclerosis in Hamsters With Severe Refractory Hypercholesterolemia. | 2022 |
1 |
| 5 |
35605828 | Protein-based HDL subspecies: Rationale and association with cardiovascular disease, diabetes, stroke, and dementia. | 2022 May 20 |
1 |
| 6 |
33257283 | Association of apolipoprotein C3 with insulin resistance and coronary artery calcium in patients with type 1 diabetes. | 2021 Jan-Feb |
1 |
| 7 |
34426648 | Changes in gut-microbiota-related metabolites and long-term improvements in lipoprotein subspecies in overweight and obese adults: the POUNDS lost trial. | 2021 Dec |
3 |
| 8 |
34458211 | Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III. | 2021 |
1 |
| 9 |
31917184 | Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects. | 2020 Jan - Feb |
2 |
| 10 |
31996466 | A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides. | 2020 Jan 29 |
1 |
| 11 |
32045574 | HDL-associated apoCIII plays an independent role in predicting postprandial hypertriglyceridemia. | 2020 May |
2 |
| 12 |
32450892 | ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity. | 2020 May 25 |
1 |
| 13 |
32949947 | Common APOC3 variants are associated with circulating ApoC-III and VLDL cholesterol but not with total apolipoprotein B and coronary artery disease. | 2020 Oct |
4 |
| 14 |
33053221 | A Versatile Nonviral Delivery System for Multiplex Gene-Editing in the Liver. | 2020 Nov |
1 |
| 15 |
31247940 | Effects of Fructose or Glucose on Circulating ApoCIII and Triglyceride and Cholesterol Content of Lipoprotein Subfractions in Humans. | 2019 Jun 26 |
1 |
| 16 |
31836003 | Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease. | 2019 Dec 13 |
1 |
| 17 |
29301387 | Pharmacogenetics of Vascular Risk Factors in Alzheimer's Disease. | 2018 Jan 3 |
1 |
| 18 |
29348120 | APOC3 Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular Risk: Mediation- and Meta-Analyses of 137 895 Individuals. | 2018 Mar |
2 |
| 19 |
28395986 | A decade of progress on the genetic basis of coronary artery disease. Practical insights for the internist. | 2017 Jun |
1 |
| 20 |
28915626 | HDL-cholesterol concentration in pregnant Chinese Han women of late second trimester associated with genetic variants in CETP, ABCA1, APOC3, and GALNT2. | 2017 Aug 22 |
1 |
| 21 |
29180722 | Rare non-coding variants are associated with plasma lipid traits in a founder population. | 2017 Nov 27 |
2 |
| 22 |
27059980 | APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases. | 2016 Aug |
1 |
| 23 |
25740221 | Methods for association analysis and meta-analysis of rare variants in families. | 2015 May |
1 |
| 24 |
26069232 | Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics. | 2015 Aug |
1 |
| 25 |
22848358 | Hypercholesterolemia is associated with the apolipoprotein C-III (APOC3) genotype in children receiving HAART: an eight-year retrospective study. | 2012 |
1 |
| 26 |
21080234 | Presence of apolipoprotein C-III attenuates apolipoprotein E-mediated cellular uptake of cholesterol-containing lipid particles by HepG2 cells. | 2011 Apr |
4 |
| 27 |
21986282 | Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease. | 2011 Nov 8 |
2 |
| 28 |
19292868 | Novel genes in cell cycle control and lipid metabolism with dynamically regulated binding sites for sterol regulatory element-binding protein 1 and RNA polymerase II in HepG2 cells detected by chromatin immunoprecipitation with microarray detection. | 2009 Apr |
2 |
| 29 |
19424489 | Apolipoprotein C3 polymorphisms, cognitive function and diabetes in Caribbean origin Hispanics. | 2009 |
2 |
| 30 |
19900229 | Serum apolipoprotein C-III in high-density lipoprotein: a key diabetogenic risk factor in Turks. | 2009 Oct |
3 |
| 31 |
18837799 | Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome. | 2008 Oct |
2 |
| 32 |
16702309 | Plasma triglyceride and HDL-cholesterol concentrations in Vietnamese girls are affected by lipoprotein lipase, but not apolipoprotein CIII polymorphism. | 2006 Jun |
2 |
| 33 |
16759053 | Association of apolipoproteins C3 and E with metabolic changes in HIV-infected adults treated with a protease-inhibitor-containing antiretroviral therapy. | 2006 |
2 |
| 34 |
15642486 | Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort. | 2005 Jan-Feb |
1 |
| 35 |
15962178 | APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian children. | 2005 Apr |
2 |
| 36 |
15044382 | Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons. | 2004 May 15 |
1 |
| 37 |
15058756 | [Levels of apoproteins B, A1 and CIII as markers for cardiovascular risk in lean and obese adolescents]. | 2004 Mar |
1 |
| 38 |
15126543 | Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women. | 2004 May |
1 |
| 39 |
15375785 | Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses. | 2004 Oct |
1 |
| 40 |
12867543 | Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism. | 2003 Oct |
1 |
| 41 |
14612212 | Interaction between the APOC3 gene promoter polymorphisms, saturated fat intake and plasma lipoproteins. | 2003 Oct |
2 |
| 42 |
12006394 | Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring Study. | 2002 May 1 |
1 |
| 43 |
11162594 | Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. | 2001 Jan 26 |
1 |
| 44 |
11500189 | Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. | 2001 Sep |
1 |
| 45 |
11714857 | Genetic influences on lipid metabolism trait variability within the Stanislas Cohort. | 2001 Nov |
1 |
| 46 |
10972686 | Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1. | 2000 Sep |
1 |
| 47 |
11031214 | Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis. | 2000 Oct |
1 |
| 48 |
10030402 | Genetic association of five apolipoprotein polymorphisms with serum lipoprotein-lipid levels in African blacks. | 1999 |
8 |
| 49 |
10559017 | Severe hyperlipidemia in apolipoprotein E2 homozygotes due to a combined effect of hyperinsulinemia and an SstI polymorphism. | 1999 Nov |
1 |
| 50 |
9209175 | Influence of the SstI polymorphism at the apolipoprotein C-III gene locus on the plasma low-density-lipoprotein-cholesterol response to dietary monounsaturated fat. | 1997 Jul |
1 |